University of Thessaly (UTH)
Διερεύνηση της επίδρασης των κορτικοστεροειδών, του αγγειακού ενδοθηλιακού αυξητικού παράγοντα (VEGF) και αναστολέων τους στη διαπερατότητα του περιτοναίου προβάτου
Abstract
dc:descriptionThe number of patients with end-stage renal disease is continuously increased in the past few years worldwide, in greek population as well. In the end stage of uremia a replacement treatment of peritoneal dialysis (PD) is applied in the 15% of dialysis patients. During PD the semi-permeable peritoneal membrane is used as a filter. Τhe hypertonic PD solutions are bioincompatible with the peritoneum physiology. As a result repeated episodes of peritonitis, fibrosis and disorders of angiogenesis eventuate. Finally, it occur high incidence of ultrafiltration failure in 50% of PD patients treated for more than 6 years and inadequacy of method. Peritoneal mesothelium and mesothelial cells play important role in the maintenance of the membrane as a biological barrier. The aim of the present thesis was the electrophysiological study in sheep peritoneum of dexamethasone, a glucocorticoid (corticosteroid) known for its anti-inflammatory effect and vascular endothelial growth factor (VEGF), which possibly appears to be involved in the pathophysiology of peritoneal fibrosis. Permeability experiments in peritoneal and visceral sheep peritoneum were performed by Ussing technique. This method allows the measurement of transmesothelial resistance, and permeability conclusions are thus drawn for the ionic permeability of peritoneal membrane. Dexamethasone rapidly increased the permeability of sheep peritoneum. This action was partially achieved via glucocorticoid and mineralocorticoid receptors. It was also mediated via the activation of amiloride-sensitive sodium channels, Na+/H+ exchanger and the activation of Na+/K+ATPase. VEGF rapidly increased the permeability of sheep peritoneal membrane and this action was mediated through VEGFR2 receptors. The result of the present study in sheep peritoneum give first evidence of how dexamethasone might contribute toward better ultrafiltration, by increasing the transport of sodium and water during a PD dwell. The direct action of VEGF indicates a potential role of VEGF in the cohesion of the peritoneal membrane and consequently in the course of PD. Τhe isolation and culture of human peritoneal mesothelial cells was achieved and initial permeability experiments were performed at Ussing apparatus.
Degree
thesis:*- Grantor dc:publisher
- University of Thessaly (UTH)
- Year dc:date
- 2010
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Karyoti, Angeliki
- Καρυώτη, Αγγελική
Subjects
dc:subject × 19- Περιτοναίο
- Διαπερατότητα
- Δεξαμεθαζόνη
- Αγγειακός ενδοθηλιακός αυξητικός παράγοντας (VEGF)
- Περιτοναϊκή κάθαρση
- Μεσοθήλιο
- Χρόνια νεφρική ανεπάρκεια (ΧΝΑ)
- Peritoneum
- Permeability
- Ussing
- Dexamethasone
- Vascular endothelial growth factor (VEGF)
- Peritoneal dialysis
- Mesothelium
- Chronic renal disease
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Medical and Health Sciences
- Basic Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/23191